Liver Fibrosis in Non-alcoholic Fatty Liver Disease: From Liver Biopsy to Non-invasive Biomarkers in Diagnosis and Treatment

An increasing percentage of people have or are at risk to develop non-alcoholic fatty liver disease (NAFLD) worldwide. NAFLD comprises different stadia going from isolated steatosis to non-alcoholic steatohepatitis (NASH). NASH is a chronic state of liver inflammation that leads to the transformatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Heyens, Leen J. M., Busschots, Dana, Koek, Ger H., Robaeys, Geert, Francque, Sven
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8079659/
https://www.ncbi.nlm.nih.gov/pubmed/33937277
http://dx.doi.org/10.3389/fmed.2021.615978

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8079659/
https://www.ncbi.nlm.nih.gov/pubmed/33937277
http://dx.doi.org/10.3389/fmed.2021.615978

Ejemplares similares